Stewart L. Fisher

Chief Scientific Officer at C4 Therapeutics

Stewart L. Fisher, Ph.D. has extensive experience in the field of biochemistry and drug discovery. Stewart L. is currently the Chief Scientific Officer at C4 Therapeutics, Inc., where they oversee the Discovery Sciences department and focuses on the development of small molecules that promote target protein degradation. Prior to this, they worked as the Director of Microbial Therapeutics at Broad Institute and as a Principal at SL Fisher Consulting, LLC, where they provided expert advice on various aspects of biochemistry and drug discovery. Dr. Fisher has also held leadership positions at AstraZeneca, where they managed a large group of infection specialists and led multiple research programs in the area of drug discovery. Stewart L. has a strong background in enzymology, biophysics, and pharmacology, and has contributed to the advancement of several drug development projects throughout their career.

Stewart L. Fisher, Ph.D., has a comprehensive education history. Stewart L. began their academic journey at the University of Vermont, where they earned their Bachelor of Arts degree in Chemistry and Computer Science from 1985 to 1989. Following this, they pursued their passion for Chemistry at Caltech and obtained their Ph.D. from 1989 to 1993.

Dr. Fisher's dedication to scientific research continued as they undertook a National Institutes of Health Post-Doctoral Fellowship at Harvard Medical School, specializing in Enzymology and Genetics from 1994 to 1996. This experience further contributed to their expertise in their respective field.

Moreover, Dr. Fisher also engaged in Continuing Education through Executive Leadership Training at Harvard Business School, enhancing their knowledge and skills in this area until 2012. The training likely provided him with additional leadership competencies to complement their scientific background.

With their diverse educational background and extensive training, Dr. Fisher demonstrates a commitment to continuously expanding their knowledge and expertise in both the scientific and business realms.

Links

Previous companies

AstraZeneca logo

Timeline

  • Chief Scientific Officer

    May, 2018 - present

  • Senior Vice President Discovery Sciences

    April, 2016

View in org chart